MARKET INTRODUCTION
The pediatric vaccine is used to strengthen the immune system of children during their developing phase. It is mandatory to immunize children with vaccines to prevent incidences of chronic diseases such as Hepatitis B, Measles, and infectious diseases, and others. Children are injected with a vaccine until they reach their adolescence phase.
MARKET DYNAMICS
The pediatric vaccine market is estimated to grow due to key factors such as the rising prevalence of chronic respiratory diseases, infectious diseases, and others among children. The market is also expected to grow due to the growing birth rate across the world. The vaccine market is expected to have growth opportunities in developing countries where the incidences of infectious diseases are more among children.
MARKET SCOPE
The "Global Pediatric Vaccine Market Analysis to 2028" is a specialized and in-depth study of the pharmaceuticals industry with a special focus on the global market trend analysis. The report aims to provide an overview of pediatric vaccine market with detailed market segmentation by type, technology, application, and geography. The global pediatric vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading pediatric vaccine market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global pediatric vaccine market is segmented on the basis of type, technology, and application. Based on the type the market is classified as monovalent, and multivalent. On the basis of technology the market is divided into live attenuated, inactivated, toxoid, conjugate, and other technologies. On the basis of application the market is segmented as infectious disease, allergy, and other applications.

REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global pediatric vaccine market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The pediatric vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting pediatric vaccine market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the pediatric vaccine market in these regions.

MARKET PLAYERS
The reports cover key developments in the pediatric vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from pediatric vaccine market are anticipated to lucrative growth opportunities in the future with the rising demand for pediatric vaccine market in the global market. Below mentioned is the list of few companies engaged in the Pediatric vaccine market.
The report also includes the profiles of key pediatric vaccine market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Novartis AG
- AstraZeneca plc
- Sanofi
- Seqirus
- Pfizer Inc
- Merck and Co., Inc
- GlaxoSmithKline plc
- Serum Institute of India Pvt. Ltd
- Panacea Biotec Ltd.
- Eli Lilly and Company
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.